dionysos
Senior Member
Are we wasting our time with Tirzepatide and Retatrutide?
Express your opinions please!
CagriSema Phase Three Studies are in progress right now.
A Phase Two Study showed the amazing CagriSema results I've quoted here:
"a fixed-dose combination therapy of 2.4mg semaglutide with 2.4mg cagrilintide"
... caused a decrease in bodyweight at Week 32 of treatment by 15.6% ...
... Zepbound caused a bodyweight decrease at 72 weeks of 15% from baseline at the lowest dose, and 20.9% at the highest dose (15mg)...
... CagriSema is likely to cause a bigger change in body weight... than even the highest dose of Zepbound ...
Link to CagriSema Phase Two Study:
Novo Nordisk launches trial of pipeline drug CagriSema versus newly approved Zepbound
Express your opinions please!
CagriSema Phase Three Studies are in progress right now.
A Phase Two Study showed the amazing CagriSema results I've quoted here:
"a fixed-dose combination therapy of 2.4mg semaglutide with 2.4mg cagrilintide"
... caused a decrease in bodyweight at Week 32 of treatment by 15.6% ...
... Zepbound caused a bodyweight decrease at 72 weeks of 15% from baseline at the lowest dose, and 20.9% at the highest dose (15mg)...
... CagriSema is likely to cause a bigger change in body weight... than even the highest dose of Zepbound ...
Link to CagriSema Phase Two Study:
Novo Nordisk launches trial of pipeline drug CagriSema versus newly approved Zepbound
Last edited: